BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J, Teichman J. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J 2016;10:E136-55. [PMID: 27790294 DOI: 10.5489/cuaj.3786] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Aftreth OP, Tenggardjaja CF, Reyblat P. Cystectomy for Benign Indications. Curr Urol Rep 2022. [PMID: 36057019 DOI: 10.1007/s11934-022-01100-1] [Reference Citation Analysis]
2 Koven A, Herschorn S. NIRS: Past, Present, and Future in Functional Urology. Curr Bladder Dysfunct Rep 2022;:1-9. [PMID: 35971538 DOI: 10.1007/s11884-022-00665-4] [Reference Citation Analysis]
3 Horváth A, Vasvári G, Lovász S, Horváth G, Birinyi P. Formulation and examination of a new urine alkalizing tablet for the symptomatic treatment of bladder pain syndrome. Journal of Drug Delivery Science and Technology 2022;74:103537. [DOI: 10.1016/j.jddst.2022.103537] [Reference Citation Analysis]
4 Jo JK, Kim YT. The Diagnosis of Chronic Pelvic Pain: How Can We Detect Urological Pain? Int Neurourol J 2022;26:87-91. [DOI: 10.5213/inj.2142116.058] [Reference Citation Analysis]
5 Brière R, Bouchard F, Ismail S, Gareau Labelle AK, Tu LM. A pilot study on oral cyclosporine A in association with fulguration for the treatment of interstitial cystitis with Hunner's lesions. Neurourol Urodyn 2022. [PMID: 35731015 DOI: 10.1002/nau.24997] [Reference Citation Analysis]
6 Tholemeier LN, Bresee C, De Hoedt AM, Barbour KE, Kim J, Freedland SJ, Anger JT. Do medication prescription patterns follow guidelines in a cohort of women with interstitial cystitis/bladder pain syndrome? Neurourol Urodyn 2022. [PMID: 35391498 DOI: 10.1002/nau.24923] [Reference Citation Analysis]
7 Dal Farra F, Aquino A, Tarantino AG, Origo D. Effectiveness of Myofascial Manual Therapies in Chronic Pelvic Pain Syndrome: A Systematic Review and Meta-Analysis. Int Urogynecol J 2022. [PMID: 35389057 DOI: 10.1007/s00192-022-05173-x] [Reference Citation Analysis]
8 Fischer-Grote L, Fössing V, Aigner M, Boeckle M, Fehrmann E. Comorbidities of bladder pain syndrome in the context of the HITOP distress category: a systematic review and meta-analysis. Int Urogynecol J 2022. [PMID: 35262767 DOI: 10.1007/s00192-022-05129-1] [Reference Citation Analysis]
9 Madurga Patuel B, González-lópez R, Resel Folkersma L, Machado Fernández G, Adot Zurbano J, Bonillo M, Vozmediano Chicharro R, Zubiaur Líbano C. Recomendaciones sobre el uso de las instilaciones endovesicales de ácido hialurónico en el síndrome de dolor vesical. Actas Urológicas Españolas 2022;46:131-7. [DOI: 10.1016/j.acuro.2021.11.006] [Reference Citation Analysis]
10 Kailavasan M, Goddard JC. Association of Elmiron (pentosanpolysulphate sodium) with pigmented maculopathy: An update for urologists and patients. Journal of Clinical Urology. [DOI: 10.1177/20514158211053699] [Reference Citation Analysis]
11 Akiyama Y, Niimi A, Igawa Y, Nomiya A, Yamada Y, Sato Y, Kawai T, Yamada D, Kume H, Homma Y. Cystectomy for patients with Hunner-type interstitial cystitis at a tertiary referral center in Japan. Low Urin Tract Symptoms 2021. [PMID: 34704374 DOI: 10.1111/luts.12416] [Reference Citation Analysis]
12 Hsieh KL, Chin HY, Lo TS, Long CY, Ho CH, Huang SK, Chuang YC, Wu MP. Interstitial cystitis/bladder pain syndrome patient is associated with subsequent increased risks of outpatient visits and hospitalizations: A population-based study. PLoS One 2021;16:e0256800. [PMID: 34492065 DOI: 10.1371/journal.pone.0256800] [Reference Citation Analysis]
13 Taidi Z, Zhou T, Moore KH, Mansfield KJ, Liu L. P2X7 Receptor Blockade Protects Against Acrolein-Induced Bladder Damage: A Potential New Therapeutic Approach for the Treatment of Bladder Inflammatory Diseases. Front Pharmacol 2021;12:682520. [PMID: 34456718 DOI: 10.3389/fphar.2021.682520] [Reference Citation Analysis]
14 Rosenberg D, Sarraf D, Chaudhary V. Maculopathie causée par le polysulfate de pentosan. CMAJ 2021;193:E1147-8. [PMID: 34312174 DOI: 10.1503/cmaj.201900-f] [Reference Citation Analysis]
15 Graf S. [Treatment of bladder pain syndrome. A network meta-analysis]. Urologe A 2021;60:1035-8. [PMID: 34226948 DOI: 10.1007/s00120-021-01588-4] [Reference Citation Analysis]
16 Nguyen LN, Cox A. Practice-changing publications in functional urology: A case-based approach. Can Urol Assoc J 2021;15:E330-4. [PMID: 34264814 DOI: 10.5489/cuaj.7468] [Reference Citation Analysis]
17 Ni B, Chen Z, Shu L, Shao Y, Huang Y, Tamrat NE, Wei Z, Shen B. Nrf2 Pathway Ameliorates Bladder Dysfunction in Cyclophosphamide-Induced Cystitis via Suppression of Oxidative Stress. Oxid Med Cell Longev 2021;2021:4009308. [PMID: 34306306 DOI: 10.1155/2021/4009308] [Reference Citation Analysis]
18 Bezruk VV, Bezruk TO, Godovanets OS, Sheremet MI, Yurniuk SV, Velia MI, Makarova OV, Yurkiv OI, Maksymiv OO. Peculiarities of the regional dynamics of the prevalence and incidence of cystitis in children. J Med Life 2021;14:210-5. [PMID: 34104244 DOI: 10.25122/jml-2020-0121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel C, Doiron C, Gilron I. Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review. JMIR Res Protoc 2021;10:e21909. [PMID: 33999006 DOI: 10.2196/21909] [Reference Citation Analysis]
20 Rosenberg D, Sarraf D, Chaudhary V. Maculopathy caused by pentosan polysulfate. CMAJ 2021;193:E645. [PMID: 33941523 DOI: 10.1503/cmaj.201900] [Reference Citation Analysis]
21 Maharaj D, Srinivasan G, Makepeace S, Hickey CJ, Gouvea J. Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome. J Pers Med 2021;11:342. [PMID: 33923265 DOI: 10.3390/jpm11050342] [Reference Citation Analysis]
22 Lin KB, Wu MP, Lin YK, Yen YC, Chuang YC, Chin HY. Lifestyle and behavioral modifications made by patients with interstitial cystitis. Sci Rep 2021;11:3055. [PMID: 33542405 DOI: 10.1038/s41598-021-82676-5] [Reference Citation Analysis]
23 Sholan R. Clinical manifestations and results of cystoscopy in women with interstitial cystitis/bladder pain syndrome. North Clin Istanb 2020;7:417-24. [PMID: 33163875 DOI: 10.14744/nci.2020.23245] [Reference Citation Analysis]
24 Gracely A, Cameron AP. Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults. Drugs Aging 2021;38:1-16. [PMID: 33094445 DOI: 10.1007/s40266-020-00810-w] [Reference Citation Analysis]
25 . Treatment of Interstitial Cystitis/Bladder Pain Syndrome: A Contemporary Review. EMJ. [DOI: 10.33590/emj/20-00029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Colemeadow J, Sahai A, Malde S. Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options. Res Rep Urol 2020;12:331-43. [PMID: 32904438 DOI: 10.2147/RRU.S238746] [Reference Citation Analysis]
27 McKernan LC, Bonnet KR, Finn MTM, Williams DA, Bruehl S, Reynolds WS, Clauw D, Dmochowski RR, Schlundt DG, Crofford LJ. Qualitative Analysis of Treatment Needs in Interstitial Cystitis/Bladder Pain Syndrome: Implications for Intervention. Can J Pain 2020;4:181-98. [PMID: 33367196 DOI: 10.1080/24740527.2020.1785854] [Reference Citation Analysis]
28 Imamura M, Scott NW, Wallace SA, Ogah JA, Ford AA, Dubos YA, Brazzelli M. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis. Cochrane Database Syst Rev 2020;7:CD013325. [PMID: 32734597 DOI: 10.1002/14651858.CD013325.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Khullar V, Digesu GA, Veit-Rubin N, Sahai A, Rahnama'i MS, Tarcan T, Chermansky C, Dmochowski R. How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018. Neurourol Urodyn 2019;38 Suppl 5:S71-81. [PMID: 31821630 DOI: 10.1002/nau.24245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
30 Dayem AA, Kim K, Lee SB, Kim A, Cho SG. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives. J Clin Med 2020;9:E766. [PMID: 32178321 DOI: 10.3390/jcm9030766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Garzon S, Laganà AS, Casarin J, Raffaelli R, Cromi A, Sturla D, Franchi M, Ghezzi F. An update on treatment options for interstitial cystitis. Prz Menopauzalny 2020;19:35-43. [PMID: 32699542 DOI: 10.5114/pm.2020.95334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Grinberg K, Weissman-Fogel I, Lowenstein L, Abramov L, Granot M. How Does Myofascial Physical Therapy Attenuate Pain in Chronic Pelvic Pain Syndrome? Pain Res Manag 2019;2019:6091257. [PMID: 31915499 DOI: 10.1155/2019/6091257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Greiman A, Cox L. Pharmacotherapy for Interstitial Cystitis/Bladder Pain Syndrome. Curr Bladder Dysfunct Rep 2019;14:365-76. [DOI: 10.1007/s11884-019-00540-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Khullar V, Chermansky C, Tarcan T, Rahnama'i MS, Digesu A, Sahai A, Veit-Rubin N, Dmochowski R. How can we improve the diagnosis and management of bladder pain syndrome? Part 1: ICI-RS 2018. Neurourol Urodyn 2019;38 Suppl 5:S66-70. [PMID: 31578775 DOI: 10.1002/nau.24166] [Reference Citation Analysis]
35 Lander EB, Berman MH, See JR. Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction stem cells. Ther Adv Urol 2019;11:1756287219868590. [PMID: 31452686 DOI: 10.1177/1756287219868590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Aydogan TB, Gurpinar O, Eser OK, Mathyk BA, Ergen A. A new look at the etiology of interstitial cystitis/bladder pain syndrome: extraordinary cultivations. Int Urol Nephrol 2019;51:1961-7. [PMID: 31363960 DOI: 10.1007/s11255-019-02248-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
37 Collings R, Healey M, Dior U, Erwin R, Rosamilia A, Cheng C. Effect of investigative laparoscopy on bladder pain syndrome: a prospective cohort trial. Int Urogynecol J 2020;31:1583-91. [PMID: 31240363 DOI: 10.1007/s00192-019-04023-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Jensen MM, Jia W, Schults AJ, Isaacson KJ, Steinhauff D, Green B, Zachary B, Cappello J, Ghandehari H, Oottamasathien S. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome. Biomaterials 2019;217:119293. [PMID: 31276948 DOI: 10.1016/j.biomaterials.2019.119293] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
39 Pape J, Falconi G, De Mattos Lourenco TR, Doumouchtsis SK, Betschart C. Variations in bladder pain syndrome/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines. Int Urogynecol J 2019;30:1795-805. [PMID: 31073635 DOI: 10.1007/s00192-019-03970-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
40 Yu WR, Peng TC, Yeh HL, Kuo HC. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome. Neurourol Urodyn 2019;38:1602-10. [PMID: 31059599 DOI: 10.1002/nau.24019] [Reference Citation Analysis]
41 Taidi Z, Mansfield KJ, Bates L, Sana-Ur-Rehman H, Liu L. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation. Bladder (San Franc) 2019;6:e38. [PMID: 32775480 DOI: 10.14440/bladder.2019.789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Huffman MM, Slack A, Hoke M. Bladder Pain Syndrome. Prim Care 2019;46:213-21. [PMID: 31030822 DOI: 10.1016/j.pop.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Morales-Solchaga G, Zubiaur-Libano C, Peri-Cusí L, Adot-Zurbano JM, Arlandis-Guzmán S, Franco-de Castro A, Castillejo C; Grupo de Investigación de Resultados en Salud en Urología Funcional y Urodinámica (Grupo IFU). Bladder pain syndrome: Prevalence and routine clinical practice in women attending functional urology and urodynamics units in Spain. Actas Urol Esp (Engl Ed) 2019;43:62-70. [PMID: 30262204 DOI: 10.1016/j.acuro.2018.06.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Simsir A, Kizilay F, Ozyurt C. The effect of Hydrodistension in combination with Pentosan Polysulfate on treatment outcomes and compliance in the treatment of bladder pain syndrome. Pak J Med Sci 2019;35:189-94. [PMID: 30881421 DOI: 10.12669/pjms.35.1.172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Goucher G, Saad F, Lukka H, Kapoor A. Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis. Can Urol Assoc J 2019;13:15-23. [PMID: 30721124 DOI: 10.5489/cuaj.5788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
46 Acar Ö, Tarcan T. Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome. J Turk Ger Gynecol Assoc 2019;20:117-22. [PMID: 30457110 DOI: 10.4274/jtgga.galenos.2018.2018.0102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Malde S, Palmisani S, Al-Kaisy A, Sahai A. Guideline of guidelines: bladder pain syndrome. BJU Int 2018;122:729-43. [PMID: 29777618 DOI: 10.1111/bju.14399] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
48 Cox A. Management of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J 2018;12:S157-60. [PMID: 29875041 DOI: 10.5489/cuaj.5324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Ogawa T, Ishizuka O, Ueda T, Tyagi P, Chancellor MB, Yoshimura N. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play. Expert Rev Clin Pharmacol 2018;11:495-505. [PMID: 29575959 DOI: 10.1080/17512433.2018.1457435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
50 Bishop LA. Management of Chronic Pelvic Pain. Clin Obstet Gynecol 2017;60:524-30. [PMID: 28742584 DOI: 10.1097/GRF.0000000000000299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Vera PL, Preston DM, Moldwin RM, Erickson DR, Mowlazadeh B, Ma F, Kouzoukas DE, Meyer-Siegler KL, Fall M. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients. Urology 2018;116:55-62. [PMID: 29580781 DOI: 10.1016/j.urology.2018.02.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
52 Lee M, Chang K, Tsai W. Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome. Int Urogynecol J 2018;29:1045-50. [DOI: 10.1007/s00192-018-3574-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Basu AS, Majerus S, Ferry E, Makovey I, Zhu H, Damaser MS. Is submucosal bladder pressure monitoring feasible? Proc Inst Mech Eng H 2019;233:100-13. [PMID: 30799738 DOI: 10.1177/0954411918754925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
54 Lusty A, Kavaler E, Zakariasen K, Tolls V, Nickel JC. Treatment effectiveness in interstitial cystitis/bladder pain syndrome: Do patient perceptions align with efficacy-based guidelines? Can Urol Assoc J 2018;12:E1-5. [PMID: 29173267 DOI: 10.5489/cuaj.4505] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
55 Allaire C, Aksoy T, Bedaiwy M, Britnell S, Noga HL, Yager H, Yong PJ. An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic Pain. Journal of Endometriosis and Pelvic Pain Disorders 2017;9:77-86. [DOI: 10.5301/jeppd.5000284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
56 Mykoniatis I, Katafigiotis I, Sfoungaristos S, Yutkin V. Immunotherapy options for painful bladder syndrome: what’s the potential? Expert Opinion on Biological Therapy 2017;17:1471-80. [DOI: 10.1080/14712598.2017.1375094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
57 Oh-oka H. Clinical Efficacy of 1-Year Intensive Systematic Dietary Manipulation as Complementary and Alternative Medicine Therapies on Female Patients With Interstitial Cystitis/Bladder Pain Syndrome. Urology 2017;106:50-4. [DOI: 10.1016/j.urology.2017.02.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
58 Kelly MEM, Lehmann C, Zhou J. The Endocannabinoid System in Local and Systemic Inflammation. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2017;9:i-192. [DOI: 10.4199/c00151ed1v01y201702isp074] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]